NCT02413255View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Single- and Multiple-Doses of TAK-020 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 18, 2015

Primary Completion Date

May 4, 2017

Study Completion Date

May 4, 2017

Conditions
Healthy Volunteers
Interventions
DRUG

TAK-020

TAK-020 oral solution

DRUG

TAK-020 Placebo

TAK-020 placebo-matching oral solution

Trial Locations (1)

Unknown

Glendale

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY